Solos Endoscopy said that it has been able to increase its sales transactions due to consistent product orders from the company’s current customer base, despite a down global economy.

The company has placed an emphasis on promoting and marketing its MammoView product line to hospitals and cancer centers over the past one year.

Solos Endoscopy said that revenue for the third quarter was driven by sales from the MammoView line as well as strong sales from its standard product line with increased orders for the company’s vascular clamp system.

Solos Endoscopy president Bob Segersten said that they completed another strong quarter of sales in 2010 and year-to-date, they have delivered double-digit revenue growth in what continues to be a economic environment.